Risk factor for patient acquisition of carbapenem-resistant pseudomonas aeruginosa

• At: Seville (Spain) (2022)
• Type: Poster
• Poster code: HPS-098
• By: YI, Mei-ling ()
• Co-author(s): Mr Po-I Chen, Department of Pharmacy (Pharmacy Department, Tungs' Taichung Metroharbor Hospital., Taichung City, Taiwan China / Taichung City New Pharmacist Association., Taichung City, Taiwan)
  Mr Pei-Liang Chen, Pharmacy Department (Pharmacy Department, Tungs' Taichung Metroharbor Hospital., Taichung City, Taiwan China / Taichung City New Pharmacist Association., Taichung City, Taiwan)
  Ms Mei-ling Yi, Pharmacist (Pharmacy Department, Tungs' Taichung Metroharbor Hospital., Taichung City, Taiwan China / Taichung City New Pharmacist Association., Taichung City, Taiwan)
  
• Abstract:

  Background information:
  Treatment of infection caused by the Pseudomonas aeruginosa(PA) is becoming more challenging with each passing year. And the rates of PA resistance to carbapenems is increasing.
  
  Purpose:
  The objective of our study was to determine the difference in risk factors between infection due to carbapenem-susceptible Pseudomonas..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login